Zdrowie i gospodarka · 25/03/2016

FDA Releases Draft Guidance on Abuse Deterrence of Generic Opioid Drugs

The FDA has published a draft guidance outlining principles for evaluating the abuse deterrence of generic solid oral opioid drug products, recommending studies to demonstrate their equivalence to reference listed drugs.